Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
EMA launches brochure on medicines regulatory system
The European Medicines Agency (EMA) recently published a revised brochure on the European regulatory system for medicines. This booklet explains how the European regulatory system for medicines operates.
Brain, Mind and Pain: Written Declaration on Access to Employment
EMSP’s partners at the European Federation of Neurological Associations (EFNA) have on 24 October launched a Written Declaration on Access…
World Mental Health Day: Young people in the digital age
EMSP’s partners at Mental Health Europe joined by healthcare stakeholders and policymakers marked World Mental Health Day 2016 with a…
World Mental Health Day: Young people in the digital age
EMSP’s partners at Mental Health Europe joined by healthcare stakeholders and policymakers marked World Mental Health Day 2016 with a…
European Patient Innovation Summit: Using digital technology to improve patient care
MSP was represented at the European Patient Innovation Summit held on 4 and 5 October in Milan, Italy. Our External Relations Director Christoph Thalheim held a presentation explaining the importance of patient-relevant outcomes.
European Patient Innovation Summit: Using digital technology to improve patient care
EMSP was represented at the European Patient Innovation Summit held on 4 and 5 October in Milan, Italy. Our External…
EURORDIS: Patient survey on adverse drug reactions
EMSP is supporting a survey intiative from our partners at Rare Diseases Europe (EURODIS) aimed at reporting side-effects and receiving safety information on medicines through an app for mobile phones and tablets.
